Vertex Pharmaceuticals 통합
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionSynovus Financial Corp
Latest Disclosed Ownership10,162 shares
Latest Disclosed Value $ 3,979,846
Synovus Financial Corp reports 3.94% increase in ownership of VRTX / Vertex Pharmaceuticals Incorporated

On November 7, 2025 - Synovus Financial Corp filed a 13F-HR form disclosing ownership of 10,162 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $3,979,846 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 14, 2025 disclosing 9,777 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 3.94% during the quarter. The current value of the position is $4,488,962 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-11-07 2025-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 10,162 385 3.94 3,980 -8.57 0.0455
2025-08-14 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 9,777 1,271 14.94 4,353 5.55 0.0533
2025-05-14 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 8,506 -2,648 -23.74 4,124 -8.19 0.0533
2025-02-13 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 11,154 -5 -0.04 4,492 -13.45 0.0572
2024-11-25 2024-09-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 11,159 -111 -0.98 5,190 -1.76 0.0601
2024-11-14 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 11,159 -111 5,190 0.0310
2024-08-13 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 11,270 117 1.05 5,282 13.30 0.0698
2024-05-14 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 11,153 89 0.80 4,662 3.58 0.0606
2024-02-14 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 11,064 351 3.28 4,502 20.83 0.0637
2023-11-13 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 10,713 -1,474 -12.09 3,725 -13.13 0.0425
2023-08-08 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 12,187 3,150 34.86 4,289 50.61 0.0470
2023-05-11 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 9,037 -911 -9.16 2,847 -0.87 0.0321
2023-02-06 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 9,948 463 4.88 2,873 4.74 0.0328
2022-10-27 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 9,485 163 1.75 2,742 4.22 0.0336
2022-08-10 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 9,322 2,585 38.37 2,631 49.57 0.0309
2022-05-12 2022-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 6,737 590 9.60 1,759 30.39 0.0187
2022-02-14 2021-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 6,147 500 8.85 1,349 31.48 0.0134
2021-11-08 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 5,647 -565 -9.10 1,026 -18.05 0.0108
2021-08-11 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 6,212 58 0.94 1,252 -5.30 0.0124
2021-05-11 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 6,154 -343 -5.28 1,322 -13.93 0.0148
2021-02-11 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 6,497 146 2.30 1,536 -11.16 0.0177
2020-11-09 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 6,351 235 3.84 1,729 -2.65 0.0231
2020-08-10 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 6,116 -4,571 -42.77 1,776 -30.11 0.0257
2020-04-24 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 10,687 3,700 52.96 2,541 66.19 0.0355
2020-02-06 2019-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 6,987 133 1.94 1,529 31.81 0.0208
2019-11-01 2019-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 6,854 349 5.37 1,160 -2.77 0.0174
2019-08-08 2019-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 6,505 -6,183 -48.73 1,193 -48.89 0.0179
2019-05-09 2019-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 12,688 4,680 58.44 2,334 76.02 0.0379
2019-02-07 2018-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 8,008 -3,311 -29.25 1,326 -39.26 0.0240
2018-11-01 2018-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 11,319 9,028 394.06 2,183 458.31 0.0345
2018-08-01 2018-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,291 -62 -2.63 391 2.62 0.0065
2018-05-07 2018-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,353 2,353 381 0.0065
2017-08-09 2017-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -135 -100.00 0 -100.00
2017-05-15 2017-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 135 0 0.00 15 66.67 0.0003
2017-02-10 2016-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 135 61 82.43 9 28.57 0.0002
2016-10-28 2016-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 74 0 0.00 7 0.00 0.0002
2016-08-04 2016-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 74 0 0.00 7 16.67 0.0002
2016-05-09 2016-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 74 -3 -3.90 6 -33.33 0.0001
2016-02-08 2015-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 77 0 0.00 9 12.50 0.0002
2015-11-03 2015-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 77 19 32.76 8 14.29 0.0002
2015-08-06 2015-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 58 0 0.00 7 16.67 0.0002
2015-05-08 2015-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 58 0 0.00 6 -14.29 0.0002
2015-02-09 2014-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 58 3 5.45 7 16.67 0.0002
2014-11-06 2014-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 55 0 0.00 6 20.00 0.0002
2014-08-01 2014-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 55 -149 -73.04 5 -66.67 0.0001
2014-05-07 2014-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 204 149 270.91 15 275.00 0.0004
2014-02-10 2013-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 55 0 0.00 4 0.00 0.0001
2013-11-01 2013-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 55 55 4 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.